Ningbo Sanxing Medical Electric Co.,Ltd. (SHA:601567)
China flag China · Delayed Price · Currency is CNY
11.69
+0.03 (0.26%)
Nov 16, 2026, 3:00 PM CST

SHA:601567 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
13,38914,14014,38411,2618,9396,911
Other Revenue
221.02221.02216.26201.71158.82112.31
13,61014,36114,60011,4639,0987,023
Revenue Growth
-10.73%-1.64%27.38%25.99%29.55%-0.98%
Cost of Revenue
10,20910,4489,5847,6006,4875,259
Gross Profit
3,4013,9135,0173,8622,6111,764
Selling, General & Admin
1,9711,9291,9141,6261,188845.78
Research & Development
620.35598.27515.58463.77320.81285.94
Other Operating Expenses
96.26-14.67-71.8819.1123.3640.92
Operating Expenses
2,7672,5892,3822,1341,5221,215
Operating Income
633.331,3232,6351,7291,089548.89
Interest Expense
-137.06-124.49-95-52.75-61.33-83.25
Interest & Investment Income
308.58257.25304.98342.58123.66239.61
Currency Exchange Gain (Loss)
139.42139.42-111.9440.9255-32.97
Other Non Operating Income (Expenses)
-300.89-33.48-31.01-30.67-17.4542.5
EBT Excluding Unusual Items
643.381,5622,7022,0291,189714.77
Impairment of Goodwill
-355.86-355.86-13.6-8.68-9.49-1.79
Gain (Loss) on Sale of Investments
158.09245.13-177.13132.41-107.48103.7
Gain (Loss) on Sale of Assets
-5.470.6-0.04-0.1-1.88-7.65
Asset Writedown
48.99-8.01-11.31-1.671.57-4.59
Other Unusual Items
173.37134.83172.96111.4680.7842.38
Pretax Income
662.51,5792,6732,2621,152846.81
Income Tax Expense
212.85330399.32341.26187.04139.2
Earnings From Continuing Operations
449.641,2492,2731,921965.01707.61
Minority Interest in Earnings
-3.8625.12-13.72-17.1-16.89-17.57
Net Income
445.791,2742,2601,904948.12690.04
Net Income to Common
445.791,2742,2601,904948.12690.04
Net Income Growth
-77.39%-43.62%18.69%100.79%37.40%-27.83%
Shares Outstanding (Basic)
1,4041,4161,4121,4101,4151,380
Shares Outstanding (Diluted)
1,4041,4161,4121,4101,4151,380
Shares Change
-0.96%0.24%0.14%-0.35%2.54%-0.40%
EPS (Basic)
0.320.901.601.350.670.50
EPS (Diluted)
0.320.901.601.350.670.50
EPS Growth
-77.17%-43.75%18.52%101.49%34.00%-27.54%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,247831.91791.631,345818.7-96.3
Free Cash Flow Per Share
0.890.590.560.950.58-0.07
Dividend Per Share
0.1450.6300.8900.6500.3500.320
Dividend Growth
-89.45%-29.21%36.92%85.71%9.38%-8.57%
Gross Margin
24.99%27.25%34.36%33.69%28.70%25.11%
Operating Margin
4.65%9.22%18.05%15.08%11.97%7.82%
Profit Margin
3.28%8.87%15.48%16.61%10.42%9.83%
Free Cash Flow Margin
9.16%5.79%5.42%11.74%9.00%-1.37%
EBITDA
966.691,6322,9111,9811,317744.1
EBITDA Margin
7.10%11.37%19.94%17.29%14.48%10.60%
D&A For EBITDA
333.36308.97276.45252.77228.7195.22
EBIT
633.331,3232,6351,7291,089548.89
EBIT Margin
4.65%9.22%18.05%15.08%11.97%7.82%
Effective Tax Rate
32.13%20.90%14.94%15.09%16.23%16.44%
Revenue as Reported
13,61014,36114,60011,4639,0987,023
Advertising Expenses
-39.132.2118.0711.288.04